Welcome to LookChem.com Sign In|Join Free
  • or
2-methyl-4-chloro-8-(2',4'-dichlorophenyl)quinoline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

215115-08-5

Post Buying Request

215115-08-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

215115-08-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 215115-08-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,1,1 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 215115-08:
(8*2)+(7*1)+(6*5)+(5*1)+(4*1)+(3*5)+(2*0)+(1*8)=85
85 % 10 = 5
So 215115-08-5 is a valid CAS Registry Number.

215115-08-5Downstream Products

215115-08-5Relevant academic research and scientific papers

Tetrahydropyridino or piperidino heterocylic derivatives

-

, (2008/06/13)

A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula [I]: A-Het??[I] has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved.

Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists

Huang, Charles Q.,Wilcoxen, Keith,McCarthy, James R.,Haddach, Mustapha,Webb, Thomas R.,Gu, Jian,Xie, Yun-Feng,Grigoriadis, Dimitri E.,Chen, Chen

, p. 3375 - 3379 (2007/10/03)

A series of 4-substituted 8-aryl-2-methylquinolines 4 was designed and synthesized as highly potent antagonists for the human CRF1 receptor. This series of compounds displayed parallel SAR to other bicyclic systems such as pyrazolo[1,5-a]pyrimidines, with several compounds possessing low nanomolar binding affinity. In addition to the high potency, the basicity of this 4-aminoquinoline core may offer CRF1 antagonists with lower lipophilicity.

CRF antagonistic quino- and quinazolines

-

, (2008/06/13)

This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R1is C1-6alkyl, NR6R7, OR6or SR7; Rsu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 215115-08-5